Divyank Soni - Arcus Biosciences, Inc

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 6 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract PR001: Discovery of Etrumadenant, a First-in-class Dual A2a and A2b Adenosine Receptor Antagonist for Cancer Immunotherapy

Ehesan U. Sharif,Dillon H. Miles,Brandon R. Rosen,Joel Beatty,Jenna L. Jeffrey,Laurent P. P. Debien,Rhiannon Thomas-Tran,Debashis Mandal, Dan Direnzo,Sachie Marubayashi,Kristen Zhang,Ferdie Soriano,Elaine Ginn,Divyank Soni, Pei-Yu Chen,Lixia Jin,Steve W. Young,Matt J. Walters,Manmohan R. Leleti,Jay P. Powers

Molecular Cancer Therapeuticsno. 12_Supplement (2024)

Cited0Views0Bibtex

Discovery of Etrumadenant, a First-in-class Dual A2a and A2b Adenosine Receptor Antagonist for Cancer Immunotherapy

MOLECULAR CANCER THERAPEUTICSno. 12 (2024)

Cited0Views0Bibtex

Abstract 3862: AB474, a Potent Orally Bioavailable Inhibitor of Arginase, for the Treatment of Cancer

Sterling C. Eckard,Yu Chen,Dana Piovesan,Nell Narasappa,Timothy W. Park,Jarek Kalisiak,Eric T. Newcomb,Manmohan R. Leleti,Divyank Soni,Elaine Ginn,Jie Chen, Dan DiRenzo,Kristen Zhang,Lixia Jin,Stephen W. Young,Matthew J. Walters,Ulrike Schindler,Jay P. Powers

CANCER RESEARCH（2019）

Cited1Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn